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Abstract
Background: Illness perceptions have been shown to predict a range of psychosocial and clinical outcomes in
kidney disease; including quality of life, distress, treatment adherence and even survival in end-stage renal disease
patients on dialysis. The aim of this study was to evaluate whether illness perceptions impact mortality in incident
predialysis Chronic Kidney Disease (CKD) patients.
Methods: Over the study period between September 2015 and June 2019, a total of 200 participants with
predialysis CKD were recruited from the Nephrology Outpatient’s clinics at Mater Dei Hospital, Malta. The
participants were followed up until June 2019, and the mortality information was collected. Cox proportional
hazards models were used to examine the association between illness perceptions, and mortality risk, after
adjustment for covariates including distress, kidney function, co-morbidity and psychological distress.
Results: Of the 200 cases available for analysis, there were 43 deaths. The mean survival time was 718.55 days (min.
3 days, max. 1297 days). The cumulative survival 1-year post the assessment of the Revised Illness Perceptions
Questionnaire (IPQ–R) was 93%. Stronger identity beliefs (HR = 1.199, 95% CI: 1.060–1.357, p = 0.004), perceptions of
a chronic timeline (HR = 1.065, 95% CI: 1.003–1.132, p = 0.041), personal control beliefs (HR = 0.845, 95% CI: 0.748–
0.955, p = 0.007) and perceptions of control over the treatment (HR = 0.812, 95% CI: 0.725–0.909, p = 0.000)
demonstrated a significant association with mortality after controlling covariates.
In a subsequent saturated model, perceived identity, chronic timeline and treatment control perceptions remained
significant predictors of mortality, together with serum albumin, comorbidities and urea.
Conclusions: CKD patients’ perceptions of treatment control, perceptions of a chronic timeline and perceived
illness identity predict survival independently of clinical prognostic factors, including kidney function and co-
morbidity. Illness perceptions are important and potentially modifiable risk factors in CKD. Further studies are
required to test whether the assessment and the implementation of psychological interventions aimed to modify
maladaptive illness perceptions influence clinical outcomes in CKD.
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Background
Chronic Kidney Disease (CKD) is a worldwide health
problem which is found to affect around 14.5% of the
global population and is associated with increased mor-
bidity risk and mortality rates [1, 2]. Literature looking
into life expectancy and mortality in predialysis CKD,
has tended to focus mostly on the role of clinical factors
within this cohort. The data by Turin et al., [3] revealed
that the life expectancy in predialysis CKD is reduced
significantly for all levels of renal function below an
eGFR of 60 ml/min/1.73 m2, with the most notable
decline in life expectancy resulting in those patients with
eGFR< 30 ml/min/1.73 m2. Extra renal comorbidities
have also been associated with morbidity and mortality
in CKD [4].
Besides the clinical factors, studies have also explored
the role of psychosocial factors on mortality; whereby
psychological factors have been identified as predictors
of short-term survival in End Stage Kidney Disease
(ESKD) through their influence on self-management
behaviours, which are essential for effective and holistic
management of Kidney Disease and its treatment.
Illness perceptions and depression have been associated
with survival and mortality in ESKD patients receiving
dialysis [5, 6]. The predictive role of illness perceptions
has also been confirmed in multiple patient groups,
including patients with cardiovascular disease [7, 8],
diabetes mellitus [9], gout [10] and cancer [11].
Whilst this association has been established in other
medical cohorts and in patients with ESKD on dialysis,
more literature is needed on earlier stages of CKD to
confirm whether this association is also present and if
so, psychological care needs to be integrated as part of
the predialysis CKD routine care.
When individuals develop a physical disease, they tend
to generate a specific pattern of beliefs, representations
or perceptions of their illness. These mental representa-
tions are conceptualised within a framework of self-
regulation known as the Common-Sense Self-Regulation
Model (CS-SRM) [12, 13]. According to the model,
people make sense of a health threat by developing their
own cognitive and emotional representations also known
as illness beliefs or illness perceptions of a health threat.
The illness perceptions are thus processed in three
stages namely; interpretation, whereby the individual
forms illness perceptions based on intrinsic factors such
as demographics, knowledge or education and symptom
perception. This is followed by coping procedures, which
enables the individual to identify strategies to reduce the
health threat associated with the disease and finally
appraisal takes place whereby the individual then ana-
lyses the outcomes of the adopted coping strategies [14].
Research exploring the association between illness
perceptions and mortality in ESKD has confirmed that
patients’ beliefs are associated with mortality. In a study
by Kimmel et al., [15], an increase in the number of
perceived consequences attributed to the kidney disease
was associated with an increased mortality risk in dialy-
sis patients. Poor treatment control was also signifi-
cantly associated with mortality in end-stage kidney
disease [5, 16]. In contrast, Peterson et al., [17] found
no significant difference in illness perceptions upon
comparing a sample of ESKD survivors and non
survivors.
Depression has also been associated with a variety of
poor outcomes in ESKD, including increased hospitalisa-
tion, poor quality of life, and increased morbidity amongst
predialysis CKD patients, after controlling for demo-
graphic and clinical covariates [18]. Similarly, depressive
symptoms have been shown to predict mortality in End-
Stage Kidney Disease cohorts on dialysis [5, 6]. Proposed
causal mechanisms to explain these poor outcomes in
relation to depression include inflammation, as well as
non-adherence to therapy, an unhealthy lifestyle and poor
nutrition [5, 6, 19].
In summary, illness perceptions and depression have
been identified as predictors of short-term survival in
ESKD on dialysis, yet few studies have explored these
associations in CKD patients. Research evidence from
other clinical populations suggests that illness percep-
tions are modifiable through psychological interventions
[20]. The aim of this study was to evaluate whether
illness perceptions impact mortality in incident predialy-
sis CKD patients on controlling for covariates.
Method
Study population and data sources
The study enrolled patients with CKD treated by
Nephrologists at the Mater Dei Hospital, the main
general hospital in Malta, a small island with a popula-
tion of 441,543 people based on the Worldometer [21].
The hospital offers specialized nephrology services,
covering the entire medical network area of Malta
and Gozo. The study cohort was formed of adult
patients over 18 years of age diagnosed with Chronic
Kidney Disease and attending clinics from January
2014 to September 2015. A total of 250 participants
were approached by the medical team to take part in
this study via phone calls or during outpatient clinics.
The sample was chosen randomly by the Consultant
Nephrologists from the hospital data base of nephrol-
ogy clinics. Of these, 220 provided informed consent
to take part in the study of which 11 participants
dropped from the study, 6 participants were ineligible
to take part in the study as they had already com-
menced dialysis treatment and 3 were ineligible due
to the presence of cognitive impairment as evidenced
by the Mini Mental State Examination, MMSE [22].
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Study cohort
The Inclusion Criteria for the study included age 18
years and over, and a diagnosis of Chronic Kidney
Disease at stage 1 to 5 and the exclusion criteria includes
patients who have already commenced dialysis, patients
that have already been transplanted and severe cognitive
impairment. A standardized cognitive assessment was
conducted using the Mini Mental State Examination,
(MMSE), and a score of < 23 is indicative of a level of
cognitive impairment, in which case patients will be
excluded.
Outcome definition
Over the study period (1st September 2015– 30th June
2019), 200 patients diagnosed with Chronic Kidney
Disease were followed up with all-cause mortality
recorded as the end point. Time-zero in the survival
models, was taken at the time patients completed the
questionnaire assessments, following recruitment in the
study whilst the end point cut off score for all-cause
mortality was taken on the 30th June 2019 for all the
participants. In the event that the participants passed
away in between this time interval, the exact date was
extracted from the hospital data system. Therefore, the
survival time was assessed from time zero till the date of
event (all-cause mortality) or till the end point of the
study with the cut off being the 30th June 2019 for all
remaining participants.
Variables
The participants were assessed for their Illness Percep-
tions of Chronic Kidney Disease at the start of the study
upon recruitment.
Covariates
The following demographic details were also taken
including age, gender, ethnicity, time since diagnosis
indicated by a categorical variable composed of eight
categories (ranging from less or equal to six months,
more than six months to one year, around 2 years,
around 3 years, around 4 years, around 5 years, five to
ten years and more than ten years),treatment or nature
of disease management indicated by a categorical vari-
able composed of five categories (ranging from dietary
management, 1–2 medications, 3–4 medications, 5–9
medications and 10 or more medications), and level of
education. The following clinical data was included in
the study; eGFR (calculated using the MDRD equation
[23], Serum Creatinine (umol/l), Urea (mmol/l), Serum
Albumin (g/l), Haemoglobin (g/dL), C Reactive Protein
(CRP) (mg/L) and other extra renal comorbidity was
assessed using the Charlson comorbidity index [24]. This
information was accessed from their routine blood tests
as ordered by their Consultant Nephrologists during
their outpatient follow ups. The participants were also
assessed for their level of depression and anxiety. All
these measures were collected at the start of the study
upon recruitment.
Illness perception measurement
The Revised Illness Perceptions Questionnaire (IPQ–R)
[25] was used to assess illness representations of CKD. It
has been validated for a range of chronic conditions
including renal patients [26]. Illness identity was mea-
sured by 14 symptoms in which patients had to report
whether they experienced the symptoms and, if so,
whether they attributed the symptom to their ‘kidney
problem’. “The number of symptoms attributed to their
kidney problem were summed (range: 0–14), with higher
scores indicating increased illness identity” [25]. “The
following dimensions were measured on a 5-point Likert
scale (strongly disagree to strongly agree): consequences
(e.g. ‘my kidney problem has major consequences on my
life’), emotional representations (e.g. ‘I get depressed
when I think about my kidney problem’), timeline (e.g.
‘my kidney problem will last for a long time’), cyclical
timeline (e.g. ‘my symptoms come and go in cycles’),
illness coherence (e.g. ‘my kidney problem is a mystery
to me’), personal control (e.g. ‘I have the power to influ-
ence my kidney problem’) and treatment control (e.g.
‘my treatment can control my kidney problem’)” [25].
High scores on the timeline and consequence dimen-
sions reflect strongly held beliefs about the chronicity
and negative consequences of the condition and the cyc-
lical dimensions reflect strongly held beliefs that the
condition is cyclical in nature. High scores on the per-
sonal control, treatment control and coherence subscales
reflect strong perceptions of illness controllability and a
greater personal understanding of the condition. The
Cronbach’s alphas are presented in the results section.
Psychological distress
Given the high correlation between Patient Health Ques-
tionnaire (PHQ-9) [27] and the Generalized Anxiety
Disorder 7-item scale (GAD-7) [28] a total distress score,
termed the PHQADS [29] was used for this study. The
PHQ-ADS scale assesses different levels of distress. The
following cut off scores will be used; participants with a
score of 0–9 to outline minimal levels of distress, 10–19
to outline mild levels of distress, 20–29 to outline mod-
erate distress and 30–48 to outline severe distress. This
measure has been validated in a renal sample [6] which
showed that the PHQ-ADS is sufficiently unidimensional
to warrant a total distress score.
Ethical considerations
Ethical approval was obtained from the Mater Dei Hospital
ethics board, the Psychiatry, Nursing and Midwifery
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Research Ethics Subcommittee at King’s College London
and the University of Malta Research Ethics Committee.
Survival analysis
All-cause mortality was the outcome measure over the
study period (1st September 2015– 30th June 2019).
Time-zero in the survival models was taken at the time
patients completed the questionnaire assessments.
Patients were censored if they regained residual renal
function, received a transplant or commenced dialysis
treatment, quit the study and if they were still alive by
the end of the follow up.
Cox proportional hazards models were constructed to
examine the association between illness perceptions and
survival. All variables collected including demographic,
clinical and psychological factors were evaluated in
terms of their association with survival using Cox pro-
portional hazards models.
Adjusted survival models controlled for covariates that
demonstrated a significant univariate association with
mortality, as evaluated in Cox survival models. The
covariates were serum albumin, comorbidity score, urea,
and distress scores. The proportion-hazards assumption
was tested by entering interaction terms into the survival
models, which revealed that the assumption was met. All
data were analysed in SPSS version 26.0.
Results
Participant demographic and clinical characteristics
A summary of demographic and clinical characteristics
is shown in Table 1 (n = 200). The mean age of the sam-
ple was 69.1 years (+ 13.4). The majority of the sample
was males 62.5%. 48.5% of the sample had an eGFR be-
tween 30 and 59. The mean comorbidity score was 4.9
(+ 3.1). The level of distress was relatively high with a
mean of 18.0 (+ 10.9).
Table 2 outlines the Cronbach’s alpha for the illness
perception items as assessed by the Revised Illness
Perceptions Questionnaire (IPQ–R). It also outlines the
mean scores and standard deviation for all items and
provides an overview of the mean scores for censored
participants versus failure that is those who passed away
throughout the study period. The participants who
passed away had higher observed mean scores for iden-
tity, timeline both chronic and cyclical and had also
higher mean scores for the perceived consequences and
emotional representations. In contrast the participants
who passed away during the study had lower mean
scores for personal control, treatment control and illness
coherence.
Survival analysis
Patients were followed up for a mean of 718.55 days
(min. 3 days, max. 1297 days) during which there were
43 deaths (21.5%) over the whole study period. The
cumulative survival 1-year post-IPQ-R assessment was
93%. Over the study period, 3 patients were transferred
to other renal units (lost to follow-up), 2 regained
residual renal function and 8 were transplanted.
Unadjusted survival analysis
Table 3 outlines the univariate analysis of demographic
and clinical kidney data with all-cause mortality. In the
unadjusted Cox proportional hazards model, albumin
(HR = 0.874, 95% CI: 0.822–0.928, p = 0.000), comorbidi-
ties (HR = 1.277, 95% CI: 1.179–1.384), p = 0.000), urea,
(HR = 1.022, 95% CI: 1.009–1.035, p = 0.001) and distress
score (HR = 1.087, 95% CI: 1.048–1.128, p = 0.000) were
significantly associated with mortality. Thus suggesting
that a 1-point increase in serum albumin is associated
with a 12.6% reduction in the hazard of death, whilst a
1-point increase in comorbidities is associated with
27.7% increase in the hazard of death, a 1-point increase
in urea is associated with a 2.2% increase in the hazard
of death and a 1-point increase in distress is associated
with an 8.7% increase in the hazard of death. Therefore
albumin, comorbidities, urea and distress were identified
as potential covariates.
Table 1 Demographic and clinical characteristics of participants
Variable Statistic
Demographic Characteristics
Males, n (%) 125 (62.5)
Females, n (%) 75 (37.5)
Education level:
Primary n (%) 93 (46.5)
Secondary n (%) 80 (40.0)
Tertiary n (%) 27 (13.5)
Time since Diagnosis
Less than or equal to 6 months 20 (10.6)
More than 6months or equal to 1 year 20 (10.6)
Around 2 to 5 years 71 (37.8)
Around 6 to 10 years 31 (16.5)
More than 10 years 46 (24.5)





Mean Urea ± SD, mmol/l 17.1 + 8.7
Mean Haemoglobin ± SD, g/dl 12.5 + 1.8
Mean Serum Albumin ± SD, g/l 42.9 + 4.4
Mean Extra renal comorbidity ± SD 4.9 + 3.1
Mean Distress Score ± SD 18.0 + 10.9
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The association between the eGFR level and mortality
was non-significant (HR = 0.982, 95% CI: 0.962–1.001,
p = 0.067). Whilst the time elapsed since diagnosis was
not significantly associated with mortality in univariate
associations. This might be attributable to the relatively
small sample size. However, considering that all partici-
pants were exposed to a CKD diagnosis and that they all
had varying degrees of eGFR, it was decided that these
two factors would be also treated as covariates so as to
ensure that these factors are accounted for due to their
previous association with morbidity and mortality in
CKD cohorts [1, 2].
Individual illness perception items were explored
for their association with mortality in unadjusted and
adjusted Cox proportional hazards. As outlined in
model 1, Table 4; all the illness perceptions were
found to be significantly associated with mortality.
Adjusted models (model 2) controlled for albumin,
comorbidities, urea, distress, eGFR levels and time
elapsed. As outlined in Table 4; identity beliefs (HR =
1.199, 95% CI: 1.060–1.357, p = 0.004), perceptions of
a chronic timeline (HR = 1.065, 95% CI: 1.003–1.132,
p = 0.041), personal control beliefs (HR = 0.845, 95%
CI: 0.748–0.955, p = 0.007) and perceptions of control
over the treatment (HR = 0.812, 95% CI: 0.725–0.909,
p = 0.000) remained significant predictors of mortality
after controlling for all covariates.
Fully adjusted survival models
Finally a fully saturated model was loaded making use of
Cox Regression analysis including the four illness
perceptions items; identity, timeline, personal control
and treatment control, as well as the covariates namely
albumin, comorbidities, urea, distress scores, eGFR levels
and time elapsed. in order to create a final model outlin-
ing the significant predictors of mortality in a CKD
cohort.
Table 5 outlines the predictors of mortality and indicates
that identity (HR= 1.215, 95% CI: 1.038–1.421, p= 0.015),
treatment control (HR= 0.765 (0.635–0.922, p= 0.005) and
chronic timeline (HR= 1.043 (1.008–1.080, p= 0.011)
remained significant predictors of mortality together with
serum albumin, comorbidities and urea. Thus suggesting
that keeping all covariates constant; a 1- point increase in
the perceived identity (i.e., the number of symptoms
assigned) is associated with 21.5% increase in the hazard of
death, a 1-point increase in perceived chronic timeline is as-
sociated with a 4.3% increase in the hazard of death, whilst a
1-point increase in treatment control is associated with a
23.5% reduction in the hazard of death. In this adjusted
model, albumin, comorbidities and urea were also predictors
of survival.
Discussion
The study aimed to assess the influence of illness
perceptions on mortality in incident predialysis CKD
patients. This study provides evidence that illness beliefs
are associated with an increased risk of mortality in
CKD patients, independent of other important clinical
and demographic variables.
In univariate analyses, stronger perceptions of illness
identity, timeline beliefs (both chronic and cyclical),
greater perceived consequences and emotional repre-
sentations were associated with increased mortality. In
Table 2 Summary of illness perception scores
Censored (n-157) Failure (n = 43)
Perception Cronbach’s α Possible Range Mean SD Mean SD Mean SD
1. Identity N/A 0–14 3.74 3.28 3.29 2.85 5.37 4.15
2. Timeline- Acute/Chronic 0.95 6–30 22.25 6.21 21.75 6.16 24.07 6.08
3. Timeline -Cyclical 0.92 4–20 9.08 3.33 8.71 3.18 10.44 3.55
4. Consequences 0.91 6–30 17.87 5.70 17.20 5.42 20.33 6.06
5. Treatment Control 0.82 5–25 16.05 3.87 16.76 3.32 13.49 4.61
6. Personal Control 0.84 6–30 18.55 4.56 19.29 4.07 15.84 5.26
7. Illness Coherence 0.79 5–25 16.98 3.66 17.24 3.60 16.02 3.76
8. Emotional Representations 0.94 6–30 19.90 6.27 19.08 6.22 22.88 5.58
Table 3 Univariate survival analysis of demographic and clinical
factors
Items Hazard Ratio p value
Age HR = 1.004 (0.981–1.029) 0.714
Gender HR = 1.632 (0.897–2.970) 0.109
Education HR = 0.604 (0.206–1.769) 0.358
eGFR HR = 0.982 (0.962–1.001) 0.067
Time since diagnosis HR = 0.042 (0.000–3.758) 0.167
Albumin HR = 0.874 (0.822–0.928) 0.000
Haemoglobin HR = 0.854 (0.717–1.018) 0.077
Comorbidities HR = 1.277 (1.179–1.384) 0.000
Urea HR = 1.022 (1.009–1.035) 0.001
Distress HR = 1.087 (1.048–1.128) 0.000
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contrast, stronger beliefs regarding personal control,
treatment control and illness coherence were associated
with a reduction in mortality risk. It is speculated that
these unhelpful illness beliefs are associated with
poorer self-management behaviors which in turn may
increase the risk of adverse outcomes. Evidence from
other conditions has shown that illness perceptions
predict self-management behaviours [30] and that psy-
chological interventions designed to alter negative ill-
ness and treatment perceptions have successfully
increased adherence to medication and physical activity
[31]. Such interventional approaches are important to
explore in CKD management programs to see whether
they improve patient outcomes.
In adjusted analysis, patients who perceived more
symptoms in relation to their condition (perceived iden-
tity) had an increased hazard of death. These findings
coincide with those of Angels et al., (2015) [32] who
found that as the CKD patients deteriorate, more symp-
toms are experienced and these are perceived by patients
to be a consequence of kidney disease. In some cases
patients report difficulty in attributing their physical
symptoms to their CKD which may impact on the
strength of their illness identity [33]. Misattributing
symptoms of CKD and related treatment regimens could
influence self-management behaviours such as medica-
tion adherence and physical activity. A study by Ricardo
et al., (2013) [34] has reported that non-adherence to
treatment regimen is associated with higher rates of all-
cause mortality in chronic kidney disease and that strat-
egies for improving self-management behaviours are
vital for optimal clinical outcomes in the management of
CKD. The fact that patients who reported more per-
ceived symptoms suffered from higher mortality might
also be associated with distress. A perception of
increased severity on perceiving and interpreting symp-
toms has been associated with higher levels of distress
amongst CKD patients [35]. Previous studies have linked
depression to poor outcomes including inflammation, as
well as non-adherence to therapy, an unhealthy lifestyle
and poor nutrition [5, 6, 19].
Stronger chronicity timeline beliefs were also found to
be associated with increased mortality in adjusted
models. The presence of chronic symptoms, patient edu-
cation and learned experiences from other patients con-
tribute to this belief [36]. Difficultly in attributing
symptoms to CKD may lead patients to perceive their
illness as chronic, more unpredictable in nature, which
could impact upon patients’ sense of control and adher-
ence to self-management regimens.
Finally participants who perceived their treatment to
be less effective (poor treatment control) had a higher
hazard of mortality. This relationship remained stable
after adjusting for clinical covariates. These results are
consistent with previous studies [5, 16] in dialysis
patients which also demonstrate an association between
treatment control perceptions and mortality.
Taken together, the Common-Sense Self-Regulation
Model (CS-SRM) provides explanation in terms of that
beliefs about the treatment or medication being ineffect-
ive could influence the extent to which patients feel
motivated to regulate their illness and to adhere to treat-
ment guidelines, which may seriously increase their mor-
tality risk [12, 13].
In conclusion, CKD patients’ perceptions of treatment
control, perceptions of a chronic timeline and perceived
illness identity predict survival independently of comor-
bidities, serum albumin and urea. Further studies are
required to replicate these findings and to provide evi-
dence for the suggested mechanism.
Impact of the study
To our knowledge, this is the first report showing that
patients’ illness perceptions regarding their identity,
timeline and treatment control are related to survival in
predialysis CKD patients. The present study shed more
light on the predictors of mortality in predialysis CKD
and yielded considerable evidence for the positive
Table 4 The association between illness perception items and
survival
Model 1 Model 2
Items Unadjusted HR Adjusted HR
Identity 1.239 (1.123–1.368)* 1.199 (1.060–1.357)*
Timeline Acute / Chronic 1.076 (1.014–1.142)* 1.065 (1.003–
1.132)**
Timeline Cyclical 1.131 (1.046–1.221)* 1.029 (0.948–1.115)
Consequences 1.100 (1.039–1.164)* 1.052 (0.984–1.124)
Personal Control 0.786 (0.720–0.859)* 0.845 (0.748–0.955)*
Treatment Control 0.778 (0.713–0.849)* 0.812 (0.725–0.909)*
Illness Coherence 0.912 (0.841–
0.990)**
0.929 (0.842–1.025)
Emotional Representations 1.114 (1.050–1.181)* 1.051 (0.966–1.144)
HR and 95% CI. * p < 0.01, **p < 0.05
Adjusted for serum albumin, comorbidity score, urea, distress, eGFR level and
time elapsed
Table 5 Predictors of mortality in predialysis CKD (n = 200)
Identity HR = 1.215 (1.038–1.421) p = 0.015
Treatment Control HR = 0.765 (0.635–0.922) p = 0.005
Timeline Acute/Chronic HR = 1.043 (1.008–1.080) p = 0.011
Albumin HR = 0.917 (0.848–0.992) p = 0.031
Comorbidities HR = 1.296 (1.155–1.454) p = 0.000
Urea HR = 1.027 (1.001–1.054) P = 0.043
HR and 95% CI
Adjusted for personal control, distress score, eGFR level and time elapsed
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relationship between illness perceptions and mortality in
CKD. It has confirmed that the illness identity, a chronic
timeline and poor treatment control were significant
predictors of mortality in pre-dialysis CKD.
These findings provide additional support for the role
of cognitive and emotional representations, and the
interplay with compliance to treatment and disease
prognosis in CKD [12, 13]. In addition, if perceptions
regarding identity and treatment control indeed pose a
serious risk factor for mortality, there is hope since as
evidenced by previous studies, in contrast to other risk
factors such as age and comorbidity, illness perceptions
prove to be modifiable by psycho-educational interven-
tions [20, 37]. Thus, according to the results, by focus-
sing on changing illness perceptions as a treatment goal,
may improve both the psychological adjustment and
regulation and as well as disease prognosis in CKD.
Limitations
This study has several strengths; a good sample of pre-
dialysis CKD participants and a good consent rate, a
good response rate to questionnaires, since question-
naires were completed in the presence of the lead
researcher and good matching of data, with clinical
markers being collected in line with the psychological
markers in terms of timeframe, so as to ensure congru-
ence between the different factors. However, the study
had also a number of weaknesses, whilst being one of
the first studies looking at illness perceptions and mor-
tality in early stage predialysis CKD patients; the sample
was all recruited from the local nephrology outpatient
clinics, thus capturing the service users that make use of
government services only. In addition, the study looks at
all-cause mortality as the outcome measure and doesn’t
discriminate against the different types of deaths thus
preventing, in this way, the possibility to conduct dis-
criminatory analysis to test for any associations between
illness perceptions and different causes of death. Thus,
our results need to be interpreted with some caution.
Conclusions
In conclusion, our findings have demonstrated that ill-
ness perceptions are associated with mortality in CKD.
In our study, negative beliefs regarding the severity of
CKD, the timeline and poor treatment control predicted
increased risk of all-cause mortality, independent of
other known clinical covariates associated with disease
severity. Interestingly distress failed to predict mortality
in our cohort. Further studies are required to test
whether the assessment and the implementation of psy-
chological interventions aimed at modifying maladaptive
illness perceptions influence clinical outcomes in CKD.
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